Dr. Mikhail Yousef Imseis, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 722 E Locust St, Ness City, KS 67560 Phone: 785-798-2203 Fax: 785-798-3458 |
Eric Elton Easey, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 316 Custer St, Ness City, KS 67560 Phone: 785-798-2233 Fax: 785-798-9743 |
News Archive
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded an Advanced Technology Small Business Innovation Research grant by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
Matthew Tyska, Ph.D., recalls being intrigued, from the first day of his postdoctoral fellowship in 1999, with a nearly 30-year-old photograph.
The 2010 Mid-Atlantic Bio today completed another successful conference hosting 728 registrants from 22 states and 4 countries, with more than 400 companies and 50 qualified investors participating. Dedicated to promoting the biotechnology industry in the Mid-Atlantic region, the conference is hosted collectively by the region's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA), the Tech Council of Maryland/MdBio (MdBio) and the Virginia Biotechnology Association (VaBIO).
Ario Pharma Ltd, the Cambridge biopharmaceutical company developing innovative new approaches to treat respiratory disease, announced today that it has commenced a Phase IIa study of its TRPV1 antagonist, XEN-0501, for the treatment and prevention of cough in patients with chronic obstructive pulmonary disease (COPD). Persistent cough in COPD and other respiratory conditions present as a huge unmet medical need, with novel therapies urgently needed to improve the quality of life of patients.
Consumers who pick up their prescription medications at a pharmacy drive-through window might be jeopardizing their own safety in the name of convenience.
› Verified 5 days ago